ROB'E is a startup aiming to revolutionize cardiovascular diagnosis and intervention with its breakthrough AI-driven, robotic cardiac ultrasound system. Founded in 2020, the company's slogan "ROBotic Echocardiography" reflects its innovative approach to cardiac care. ROB'E's focus on AI, Health Care, Medical Devices, and Robotics positions it at the forefront of technological advancement in the medical field. As of now, specific information about the headquarter and last_investment are not available. However, considering the potential of AI-driven healthcare solutions, ROB'E could attract significant interest from venture capital firms and investors looking to support cutting-edge medical technologies.
There is no investment information
No recent news or press coverage available for ROB'E.